These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11961063)

  • 1. Enhanced neuroprotective effects of basic fibroblast growth factor in regional brain ischemia after conjugation to a blood-brain barrier delivery vector.
    Song BW; Vinters HV; Wu D; Pardridge WM
    J Pharmacol Exp Ther; 2002 May; 301(2):605-10. PubMed ID: 11961063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and brain uptake of biotinylated basic fibroblast growth factor conjugated to a blood-brain barrier drug delivery system.
    Wu D; Song BW; Vinters HV; Pardridge WM
    J Drug Target; 2002 May; 10(3):239-45. PubMed ID: 12075825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and blood-brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system.
    Wu D; Boado RJ; Pardridge WM
    J Pharmacol Exp Ther; 1996 Jan; 276(1):206-11. PubMed ID: 8558431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of brain-derived neurotrophic factor to a blood-brain barrier drug targeting system enables neuroprotection in regional brain ischemia following intravenous injection of the neurotrophin.
    Zhang Y; Pardridge WM
    Brain Res; 2001 Jan; 889(1-2):49-56. PubMed ID: 11166685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotection in transient focal brain ischemia after delayed intravenous administration of brain-derived neurotrophic factor conjugated to a blood-brain barrier drug targeting system.
    Zhang Y; Pardridge WM
    Stroke; 2001 Jun; 32(6):1378-84. PubMed ID: 11387502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system.
    Wu D; Pardridge WM
    J Pharmacol Exp Ther; 1996 Oct; 279(1):77-83. PubMed ID: 8858978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1-40/vector complex.
    Saito Y; Buciak J; Yang J; Pardridge WM
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10227-31. PubMed ID: 7479757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of carboxyl-directed protein pegylation and vector-mediated blood-brain barrier drug delivery system optimizes brain uptake of brain-derived neurotrophic factor following intravenous administration.
    Pardridge WM; Wu D; Sakane T
    Pharm Res; 1998 Apr; 15(4):576-82. PubMed ID: 9587954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.
    Pardridge WM; Kang YS; Buciak JL
    Pharm Res; 1994 May; 11(5):738-46. PubMed ID: 8058646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and saturable blood-brain barrier transport of biotin bound to a conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Kang YS; Bickel U; Pardridge WM
    Drug Metab Dispos; 1994; 22(1):99-105. PubMed ID: 8149897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat.
    Li Q; Stephenson D
    Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed treatment with intravenous basic fibroblast growth factor reduces infarct size following permanent focal cerebral ischemia in rats.
    Fisher M; Meadows ME; Do T; Weise J; Trubetskoy V; Charette M; Finklestein SP
    J Cereb Blood Flow Metab; 1995 Nov; 15(6):953-9. PubMed ID: 7593356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor radiopharmaceuticals: 111In chelation, conjugation to a blood-brain barrier delivery vector via a biotin-polyethylene linker, pharmacokinetics, and in vivo imaging of experimental brain tumors.
    Kurihara A; Deguchi Y; Pardridge WM
    Bioconjug Chem; 1999; 10(3):502-11. PubMed ID: 10346884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor.
    Yoshikawa T; Pardridge WM
    J Pharmacol Exp Ther; 1992 Nov; 263(2):897-903. PubMed ID: 1432704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-brain barrier drug targeting enables neuroprotection in brain ischemia following delayed intravenous administration of neurotrophins.
    Pardridge WM
    Adv Exp Med Biol; 2002; 513():397-430. PubMed ID: 12575830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention of biologic activity of human epidermal growth factor following conjugation to a blood-brain barrier drug delivery vector via an extended poly(ethylene glycol) linker.
    Deguchi Y; Kurihara A; Pardridge WM
    Bioconjug Chem; 1999; 10(1):32-7. PubMed ID: 9893961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotection in experimental stroke with targeted neurotrophins.
    Wu D
    NeuroRx; 2005 Jan; 2(1):120-8. PubMed ID: 15717063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of neutral avidin improves pharmacokinetics and brain delivery of biotin bound to an avidin-monoclonal antibody conjugate.
    Kang YS; Pardridge WM
    J Pharmacol Exp Ther; 1994 Apr; 269(1):344-50. PubMed ID: 8169841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
    Pardridge WM; Boado RJ; Kang YS
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5592-6. PubMed ID: 7777554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.